WikiTrademarks - Search, analyse, and monitor trademark applications.

Trademark: UNIVERSAL AAV IMMUNO-GENE THERAPY FOR CANCER

Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io

Tweet this

Track updates on UNIVERSAL AAV IMMUNO-GENE THERAPY FOR CANCER

Mark Identification

Proof of use for UNIVERSAL AAV IMMUNO-GENE THERAPY FOR CANCER

We do not have any records of a proof of use for UNIVERSAL AAV IMMUNO-GENE THERAPY FOR CANCER at this moment.

Click here to add a proof of use for UNIVERSAL AAV IMMUNO-GENE THERAPY FOR CANCER

Possible trademark infringements of UNIVERSAL AAV IMMUNO-GENE THERAPY FOR CANCER

Basic Information about UNIVERSAL AAV IMMUNO-GENE THERAPY FOR CANCER

Serial Number
97772311
Filing Date
30 Jan 2023
Mark Drawing Code
4

Classifications

Declare the trademark use of UNIVERSAL AAV IMMUNO-GENE THERAPY FOR CANCER on the blockchain with WikiTrademarks.io.

First use of UNIVERSAL AAV IMMUNO-GENE THERAPY FOR CANCER anywhere
No first use declared yet.
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
005
US Codes
005; 006; 018; 044; 046; 051; 052
First use of UNIVERSAL AAV IMMUNO-GENE THERAPY FOR CANCER anywhere
No first use declared yet.
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
042
US Codes
100; 101

Who owns UNIVERSAL AAV IMMUNO-GENE THERAPY FOR CANCER?

1. Siren Biotechnology, Inc. San Francisco CA

Correspondent

SIREN BIOTECHNOLOGY, INC.
455 MISSION BAY BLVD S.
455 MISSION BAY BLVD S.
SAN FRANCISCO, CA 94158

Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io

Tweet this

Track updates on UNIVERSAL AAV IMMUNO-GENE THERAPY FOR CANCER